LivingGLP1
Study S002394

RAPID-CKM: RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care.

ClinicalTrials.gov record

Registration

Registration
NCT07605390
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
600
Start
2026-08
Primary completion
2028-01
Lead sponsor
Baylor Research Institute
Conditions
Chronic Kidney Disease; Type 2 Diabetes
Interventions
OTHER:Epic-Based Clinician Notification; OTHER:Usual Care
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Initiation of Guideline-Directed Cardio-Kidney Metabolic Therapy [3 months]
  • Therapy-Specific Initiation Rate [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.